あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/05/02 | 日証協 | 103,526株 | +5.18% | 13,500株 | -94.31% | 209,637株 | +8.15% | 16,783株 | -81.93% |
2023/04/28 | 日証協 | 98,426株 | +9.86% | 237,150株 | +288.69% | 193,837株 | +1.54% | 92,883株 | +3333.75% |
2023/04/21 | 日証協 | 89,589株 | +11.93% | 61,012株 | -25.67% | 190,900株 | -13.23% | 2,705株 | -20.44% |
2023/04/14 | 日証協 | 80,037株 | -2.91% | 82,080株 | +113.88% | 219,995株 | -5.58% | 3,400株 | -95.41% |
2023/04/07 | 日証協 | 82,437株 | +8.27% | 38,376株 | -58.65% | 233,003株 | +91.72% | 74,029株 | -65.65% |
2023/03/31 | 日証協 | 76,137株 | +14.8% | 92,818株 | -5.03% | 121,533株 | -51.57% | 215,512株 | +104.11% |
2023/03/24 | 日証協 | 66,323株 | -53.2% | 97,735株 | +21.19% | 250,968株 | +9.01% | 105,587株 | +369.99% |
2023/03/17 | 日証協 | 141,728株 | -35.08% | 80,643株 | -28.3% | 230,217株 | -1.42% | 22,466株 | +26.46% |
2023/03/10 | 日証協 | 218,328株 | -1.63% | 112,465株 | +61.41% | 233,526株 | -6.57% | 17,766株 | +3.75% |
2023/03/03 | 日証協 | 221,952株 | +3.46% | 69,676株 | +82.21% | 249,950株 | +5.14% | 17,124株 | +14.29% |
2023/02/24 | 日証協 | 214,528株 | +0.7% | 38,239株 | +69.56% | 237,726株 | -0.42% | 14,983株 | -22.63% |
2023/02/17 | 日証協 | 213,028株 | -1.02% | 22,552株 | +61.79% | 238,726株 | -1.07% | 19,366株 | -42.36% |
2023/02/10 | 日証協 | 215,215株 | +2.87% | 13,939株 | -29.24% | 241,313株 | -0.79% | 33,600株 | +10.26% |
2023/02/03 | 日証協 | 209,215株 | +0.55% | 19,700株 | +2323.12% | 243,227株 | +0.04% | 30,474株 | +271.45% |
2023/01/27 | 日証協 | 208,065株 | -0.23% | 813株 | -13.97% | 243,140株 | -3.49% | 8,204株 | +2.88% |
2023/01/20 | 日証協 | 208,552株 | -3.41% | 945株 | -34.65% | 251,927株 | -1.45% | 7,974株 | -70.22% |
2023/01/13 | 日証協 | 215,921株 | -5.83% | 1,446株 | -80.29% | 255,640株 | +3.91% | 26,778株 | +9.51% |
2023/01/06 | 日証協 | 229,283株 | +0.71% | 7,338株 | -94.96% | 246,016株 | +2.12% | 24,453株 | +94.33% |
2022/12/30 | 日証協 | 227,676株 | +145.93% | 145,726株 | +230.9% | 240,916株 | -0.66% | 12,583株 | -89.53% |
※株式分割は考慮していませんのでご注意ください。
Page Top